Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Sirt6 cooperates with Blimp1 to positively regulate osteoclast differentiation.

Park SJ, Huh JE, Shin J, Park DR, Ko R, Jin GR, Seo DH, Kim HS, Shin HI, Oh GT, Kim HS, Lee SY.

Sci Rep. 2016 May 18;6:26186. doi: 10.1038/srep26186.

2.

Accelerated Lactate Dehydrogenase Activity Potentiates Osteoclastogenesis via NFATc1 Signaling.

Ahn H, Lee K, Kim JM, Kwon SH, Lee SH, Lee SY, Jeong D.

PLoS One. 2016 Apr 14;11(4):e0153886. doi: 10.1371/journal.pone.0153886. eCollection 2016.

3.

DC-STAMP: A Key Regulator in Osteoclast Differentiation.

Chiu YH, Ritchlin CT.

J Cell Physiol. 2016 Nov;231(11):2402-7. doi: 10.1002/jcp.25389. Epub 2016 Jun 14. Review.

PMID:
27018136
4.

Signaling Pathways in Osteoclast Differentiation.

Kim JH, Kim N.

Chonnam Med J. 2016 Jan;52(1):12-7. doi: 10.4068/cmj.2016.52.1.12. Epub 2016 Jan 19. Review.

5.

Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB.

Quan GH, Wang H, Cao J, Zhang Y, Wu D, Peng Q, Liu N, Sun WC.

Int J Mol Sci. 2015 Dec 10;16(12):29496-507. doi: 10.3390/ijms161226179.

6.

FOXO1 inhibits osteoclastogenesis partially by antagnozing MYC.

Tan P, Guan H, Xie L, Mi B, Fang Z, Li J, Li F.

Sci Rep. 2015 Nov 16;5:16835. doi: 10.1038/srep16835.

7.

Amlexanox Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss.

Zhang Y, Guan H, Li J, Fang Z, Chen W, Li F.

Sci Rep. 2015 Sep 4;5:13575. doi: 10.1038/srep13575.

8.

Alternative NF-κB Regulates RANKL-Induced Osteoclast Differentiation and Mitochondrial Biogenesis via Independent Mechanisms.

Zeng R, Faccio R, Novack DV.

J Bone Miner Res. 2015 Dec;30(12):2287-99. doi: 10.1002/jbmr.2584. Epub 2015 Aug 6.

PMID:
26094846
9.

Rhinacanthin C Inhibits Osteoclast Differentiation and Bone Resorption: Roles of TRAF6/TAK1/MAPKs/NF-κB/NFATc1 Signaling.

Tomomura M, Suzuki R, Shirataki Y, Sakagami H, Tamura N, Tomomura A.

PLoS One. 2015 Jun 17;10(6):e0130174. doi: 10.1371/journal.pone.0130174. eCollection 2015.

10.

Osteoimmunology: Major and Costimulatory Pathway Expression Associated with Chronic Inflammatory Induced Bone Loss.

Crotti TN, Dharmapatni AA, Alias E, Haynes DR.

J Immunol Res. 2015;2015:281287. doi: 10.1155/2015/281287. Epub 2015 May 3. Review.

11.

TMEM203 Is a Novel Regulator of Intracellular Calcium Homeostasis and Is Required for Spermatogenesis.

Shambharkar PB, Bittinger M, Latario B, Xiong Z, Bandyopadhyay S, Davis V, Lin V, Yang Y, Valdez R, Labow MA.

PLoS One. 2015 May 21;10(5):e0127480. doi: 10.1371/journal.pone.0127480. eCollection 2015.

12.

Genistein attenuates glucocorticoid-induced bone deleterious effects through regulation Eph/ephrin expression in aged mice.

Cheng Y, Wang WL, Liang JJ.

Int J Clin Exp Pathol. 2015 Jan 1;8(1):394-403. eCollection 2015.

13.

5-Azacytidine-induced protein 2 (AZI2) regulates bone mass by fine-tuning osteoclast survival.

Maruyama K, Fukasaka M, Uematsu S, Takeuchi O, Kondo T, Saitoh T, Martino MM, Akira S.

J Biol Chem. 2015 Apr 10;290(15):9377-86. doi: 10.1074/jbc.M114.631374. Epub 2015 Feb 17.

14.

A novel phthalimide derivative, TC11, has preclinical effects on high-risk myeloma cells and osteoclasts.

Matsushita M, Ozaki Y, Hasegawa Y, Terada F, Tabata N, Shiheido H, Yanagawa H, Oikawa T, Matsuo K, Du W, Yamada T, Hozumi M, Ichikawa D, Hattori Y.

PLoS One. 2015 Jan 24;10(1):e0116135. doi: 10.1371/journal.pone.0116135. eCollection 2015.

15.

SHP2 regulates osteoclastogenesis by promoting preosteoclast fusion.

Zhou Y, Mohan A, Moore DC, Lin L, Zhou FL, Cao J, Wu Q, Qin YX, Reginato AM, Ehrlich MG, Yang W.

FASEB J. 2015 May;29(5):1635-45. doi: 10.1096/fj.14-260844. Epub 2015 Jan 15.

16.

Angelica sinensis extract inhibits RANKL-mediated osteoclastogenesis by down-regulated the expression of NFATc1 in mouse bone marrow cells.

Kong L, Zhao Q, Wang X, Zhu J, Hao D, Yang C.

BMC Complement Altern Med. 2014 Dec 12;14:481. doi: 10.1186/1472-6882-14-481.

17.

Increased osteoclastogenesis in mice lacking the carcinoembryonic antigen-related cell adhesion molecule 1.

Heckt T, Bickert T, Jeschke A, Seitz S, Schulze J, Ito WD, Zimmermann W, Amling M, Schinke T, Horst AK, Keller J.

PLoS One. 2014 Dec 9;9(12):e114360. doi: 10.1371/journal.pone.0114360. eCollection 2014.

18.

Regulation of NFATc1 in Osteoclast Differentiation.

Kim JH, Kim N.

J Bone Metab. 2014 Nov;21(4):233-41. doi: 10.11005/jbm.2014.21.4.233. Epub 2014 Nov 30. Review.

20.

Fucoidan, a sulfated polysaccharide, inhibits osteoclast differentiation and function by modulating RANKL signaling.

Kim YW, Baek SH, Lee SH, Kim TH, Kim SY.

Int J Mol Sci. 2014 Oct 20;15(10):18840-55. doi: 10.3390/ijms151018840.

Items per page

Supplemental Content

Write to the Help Desk